A treatment approach for atopic dermatitis.
Dohil
Magdalene A
MA
University of Califoria San Diego School of Medicine, USA.
Eichenfield
Lawrence F
LF
D000284:Administration, Oral; D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage; D000485:Allergens; D000890:Anti-Infective Agents / Q000008:administration & dosage; D065095:Calcineurin Inhibitors; D002648:Child; D002675:Child, Preschool; D002985:Clinical Protocols; D003876:Dermatitis, Atopic / Q000175:diagnosis / Q000628:therapy*; D003879:Dermatologic Agents / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006634:Histamine H1 Antagonists / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007223:Infant; D010353:Patient Education as Topic / Q000379:methods; D010789:Phototherapy / Q000379:methods; D017592:Skin Care / Q000295:instrumentation / Q000379:methods; D016559:Tacrolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*
D000305:Adrenal Cortex Hormones; D000485:Allergens; D000890:Anti-Infective Agents; D065095:Calcineurin Inhibitors; D003879:Dermatologic Agents; D006634:Histamine H1 Antagonists; D007166:Immunosuppressive Agents; C117268:pimecrolimus; D016559:Tacrolimus